HINNAO NAD+ (Nicotinamide Adenine Dinucleotide) Until Now NAD+ has only been available in IV drip therapy clinics, due to the molecule not being stable.Using clinically proven high-stability liposomes, as a delivery mechanism HINNAO NAD+ absorbs instantly via the mucous membrane crossing the blood brain barrier.
Low NAD+ levels are associated with ageing and being more prone to chronic diseases such as diabetes, heart disease, Alzheimer’s disease and vision loss.
Using clinically proven high-stability liposomes as a delivery mechanism, HINNAO NAD+ absorbs instantly via the mucous membrane.
